Vasomedical Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vasomedical Inc.

VASO 0.173

+1.5%

Dec 17 3:27 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Antonios Petropoulos who wrote (320)	3/25/1997 6:21:00 PM
From: Victor Cassella	of 1605

THis has nothing to do with the presentation. But it came out about the same time... we should see a good run tomorrow Tuesday March 25 4:19 PM EDT New patent issued to Vasomedical patented features will broaden applications WESTBURY, N.Y.--(BW HealthWire)--March 25, 1997-- Vasomedical Inc , manufacturer and marketer of EECP(R) - a noninvasive treatment for patients suffering with angina pectoris--has received a new patent from the U.S. Patent Office encompassing multiple operating features for its EECP(R) equipment. These features will be incorporated in the future Model MC3. "The issuance of this patent helps protect important technology advances that will permit broader therapeutic application of EECP(R) therapy expanding our market opportunities", noted Anthony Viscusi, president and CEO of Vasomedical. Viscusi went on to say, "The patent covers features that will facilitate treatment of diverse patient groups as well as provide an integrated ability to monitor the patients' physical signs while undergoing treatment. We will vigorously enforce our patent rights and be vigilant about possible infringement." The new patent extends until the year 2013. Patent applications are pending in overseas markets. Vasomedical is a medical technology company devoted to the development, manufacture and commercialization of innovative and cost-effective cardiovascular products and processes. CONTACT: Vasomedical Inc. Natalie Karp, 516/997-4600 ext. 776

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next